Weight loss and side-effects of liraglutide and lixisenatide in obesity and type 2 diabetes mellitus

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) is used to treat obesity or type 2 diabetes mellitus (DM). We compared weight loss and side-effects between patients with and without DM using GLP-1 RA.

Source: Primary Care Diabetes - August 2, 2023 Category: Primary Care Authors: Jeongmin Lee, Raeun Kim, Min-Hee Kim, Seung-Hwan Lee, Jae-Hyoung Cho, Jung Min Lee, Sang-Ah Jang, Hun-Sung Kim Source Type: research